Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. Among authors: naldi l. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study.
Pezzolo E, Napolitano M, Narcisi A, Gargiulo L, Trave I, Rossi M, Satta R, Caroppo F, Pandolfi R, Guglielmo A, Nan K, Patruno C, Naldi L. Pezzolo E, et al. Among authors: naldi l. Dermatitis. 2024 Oct 3. doi: 10.1089/derm.2024.0335. Online ahead of print. Dermatitis. 2024. PMID: 39360945 No abstract available.
ChatGPT and acne: Accuracy and reliability of the information provided-The AI-check study.
Bettoli V, Naldi L, Santoro E, Valetto MR, Bolzon A, Cassalia F, Cazzaniga S, Cima S, Danese A, Emendi S, Ponzano M, Scarpa N, Dri P. Bettoli V, et al. Among authors: naldi l. J Eur Acad Dermatol Venereol. 2024 Sep 16. doi: 10.1111/jdv.20324. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39282825 No abstract available.
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.
Piraccini BM, Pampaloni F, Cedirian S, Quadrelli F, Bruni F, Rapparini L, Caro G, Acri MC, Ala L, Rossi A, Pellacani G, Lacarrubba F, Micali G, Dall'Oglio F, Vastarella M, Cantelli M, Nappa P, Diluvio L, Bianchi L, Gnesotto L, Sechi A, Naldi L, Tassone F, Peris K, Caldarola G, Pinto LM, Girolomoni G, Marangoni F, Bellinato F, Gisondi P, Scandagli I, Prignano F, Pimpinelli N, Tomasini C, Barruscotti S, De Simoni E, Simonetti O, Ambrogio F, Foti C, Boccaletti V, Fraghì A, Marzano AV, Mattioli MA, Rocca L, Barbareschi M, Ferrucci SM, Gallo G, Ribero S, Quaglino P, Balestri R, Ioris T, Caposiena Caro RD, Zalaudek I, Vagnozzi E, Fargnoli MC, Caponio C, Rubegni P, Cinotti E, Trovato E, Romanelli M, Dini V, Manzo Margiotta F, Feliciani C, de Felici Del Giudice MB, Atzori L, Sanna S, Lembo S, Raimondo A, Magnano M, Starace M. Piraccini BM, et al. Among authors: naldi l. J Eur Acad Dermatol Venereol. 2024 Sep 9. doi: 10.1111/jdv.20312. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39247945
Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment.
Ronconi G, Dondi L, Calabria S, Dondi L, Pedrini A, Esposito I, Scattareggia M, Rogliani P, Trimarchi M, Costanzo A, Patruno C, Naldi L, Martini N. Ronconi G, et al. Among authors: naldi l. Ital J Dermatol Venerol. 2024 Aug;159(4):417-424. doi: 10.23736/S2784-8671.24.07833-2. Ital J Dermatol Venerol. 2024. PMID: 39069839 Free article.
513 results